Food as Medicine: Research Aims to Understand the Power of Nutrition in Treating Cancer

… microbiome in immunotherapy efficacy. … Food as Medicine: Research Aims to Understand the Power of Nutrition in Treating …

COAST Data Support Further Research of Immunotherapy Combinations

… regardless of PD-L1 status. … COAST Data Support Further Research of Immunotherapy Combinations … Mariona Riudavets, …

NCI Launches the Cancer Moonshot SM Biobank to Accelerate Research in Cancer Treatment

… NCI Launches the Cancer Moonshot SM Biobank to Accelerate Research in Cancer Treatment … Helen M. Moore, PhD …

First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology

… First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology …

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

… with an early-stage non-small-cell lung cancer (NSCLC), research combining prospective and propensity-matched data has … microenvironment and systemic immune responses. 8  Recent research has focused on specific immune cell subsets, such as … with SABR. Substantial clinical and translational research is essential to establish the true effectiveness and …

Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy

… of ADCs with TKIs. 18  Learn more about the latest in ADC research here. Physicians and patients alike question which … failure of EGFR-TKI therapy. Translational Lung Cancer Research. 2021;10(9):3782-92. 7.  Itchins M, Ainsworth H, … COMPARING OUTCOMES OF VARIOUS TREATMENT REGIMENS IN THE SEARCH FOR THE BEST-PERFORMING APPROACH. … Challenges of …

A New Treatment Option for Early-Stage ALK+ NSCLC: Adjuvant Alectinib

… in Victoria, Australia. His clinical and translational research has identified new treatments, changed the standards … in Victoria, Australia. His clinical and translational research has identified new treatments, changed the standards …

Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question

… at correlating with event-free and overall survival. Researchers have a digital platform and AI algorithm to … with large trials have agreed to contribute their data.” Researchers will be looking to see if pCR leads to long-term …

Should Biomarkers Be Used in the Clinical Management of ES-SCLC?

… not there yet. We can’t force it.” He said having recent research that has demonstrated the heterogeneity of SCLC is a huge first step. As is other recent research showing that liquid biopsy can be used to identify …

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

Proposed Criteria for Tumor Invasion Align with Clinical Factors, Offer Better Predictability, Study Finds

… Researchers evaluating the clinical significance of …

Undruggable No More: KRAS Experts Review What is Known—and Unknown—About This Challenging Alteration

… to target this oncogenic driver. Get up to date as researchers from Roswell Park Comprehensive Cancer Center …